News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cellumen, Inc. Appoints Dr. Jack A. Reynolds to Board of Directors


3/26/2009 11:43:32 AM

PITTSBURGH--(BUSINESS WIRE)--Cellumen, Inc., a discovery toxicology company, today announced that industry veteran and former Pfizer executive Dr. Jack A. Reynolds has joined Cellumen’s board of directors. With more than 30 years of experience in the pharmaceutical industry, Dr. Reynolds is founder and Principal at JAReynolds & Associates, which is focused on defining new paradigms for improving safety testing and decision making in the pharmaceutical industry.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES